1. Home
  2. CBSH vs IMVT Comparison

CBSH vs IMVT Comparison

Compare CBSH & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Commerce Bancshares Inc.

CBSH

Commerce Bancshares Inc.

HOLD

Current Price

$59.09

Market Cap

7.6B

Sector

Finance

ML Signal

HOLD

Logo Immunovant Inc.

IMVT

Immunovant Inc.

HOLD

Current Price

$40.62

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CBSH
IMVT
Founded
1865
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.6B
8.0B
IPO Year
2008
2019

Fundamental Metrics

Financial Performance
Metric
CBSH
IMVT
Price
$59.09
$40.62
Analyst Decision
Hold
Buy
Analyst Count
8
8
Target Price
$58.28
$33.00
AVG Volume (30 Days)
1.2M
1.0M
Earning Date
04-21-2026
05-28-2026
Dividend Yield
2.15%
N/A
EPS Growth
4.39
N/A
EPS
0.96
N/A
Revenue
N/A
N/A
Revenue This Year
$17.43
N/A
Revenue Next Year
$3.43
N/A
P/E Ratio
$61.55
N/A
Revenue Growth
N/A
N/A
52 Week Low
$46.99
$14.32
52 Week High
$63.49
$41.23

Technical Indicators

Market Signals
Indicator
CBSH
IMVT
Relative Strength Index (RSI) 63.11 62.17
Support Level $51.97 $37.53
Resistance Level $59.27 $41.22
Average True Range (ATR) 0.99 1.39
MACD -0.14 -0.26
Stochastic Oscillator 57.12 75.68

Price Performance

Historical Comparison
CBSH
IMVT

About CBSH Commerce Bancshares Inc.

Commerce Bancshares Inc operates as the bank holding company for Commerce Bank. The bank is engaged in the general banking business, providing a broad range of retail, mortgage banking, corporate, investment, trust, and asset management products and services to individuals, businesses, and municipalities. The company has three reportable segments. The Commercial segment provides lending, leasing, deposit, payment, and cash management services to business and government customers. The Retail Banking segment offers consumer deposits, consumer lending, mortgage banking, and debit and credit card services through its branch network. The Wealth segment provides trust, estate planning, brokerage, and investment management services to individual and institutional clients.

About IMVT Immunovant Inc.

Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The Company operates in a single operating segment and has one reportable segment, which includes all activities related to the discovery, development and manufacturing of its product candidates.

Share on Social Networks: